NEXUS SURGICAL AND MEDICARE LI (NEXUSSURGL.BO)
INR 15.17
(0.46%)
INR 15.17
(0.46%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 34.74 Million INR | 123.68% |
| 2022 | 15.53 Million INR | -35.15% |
| 2021 | 23.95 Million INR | -36.04% |
| 2020 | 37.44 Million INR | 116.2% |
| 2019 | 17.31 Million INR | -19.03% |
| 2018 | 21.38 Million INR | 118.6% |
| 2017 | 9.78 Million INR | 221.19% |
| 2016 | 3.04 Million INR | -7.58% |
| 2015 | 3.29 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 17.6 Million INR | 194.36% |
| 2023 Q4 | 5.98 Million INR | -58.64% |
| 2023 Q1 | 10.6 Million INR | 664.82% |
| 2023 FY | 34.74 Million INR | 123.68% |
| 2023 Q2 | 3.69 Million INR | -65.17% |
| 2023 Q3 | 14.46 Million INR | 291.34% |
| 2022 Q2 | - INR | -100.0% |
| 2022 FY | 15.53 Million INR | -35.15% |
| 2022 Q4 | 1.38 Million INR | -53.77% |
| 2022 Q3 | 3 Million INR | 0.0% |
| 2022 Q1 | 11.14 Million INR | 0.0% |
| 2021 Q1 | 2.3 Million INR | -39.47% |
| 2021 Q4 | - INR | -100.0% |
| 2021 FY | 23.95 Million INR | -36.04% |
| 2021 Q3 | 17.65 Million INR | 341.25% |
| 2021 Q2 | 4 Million INR | 73.91% |
| 2020 FY | 37.44 Million INR | 116.2% |
| 2020 Q4 | 3.8 Million INR | 0.0% |
| 2019 FY | 17.31 Million INR | -19.03% |
| 2018 FY | 21.38 Million INR | 118.6% |
| 2017 FY | 9.78 Million INR | 221.19% |
| 2016 FY | 3.04 Million INR | -7.58% |
| 2015 FY | 3.29 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 2.22 Billion INR | 98.439% |
| Checkpoint Trends Limited | 11.3 Million INR | -207.2% |
| Everest Organics Limited | 1.97 Billion INR | 98.239% |
| GUJARAT INJECT (KERALA) LTD. | 57.88 Million INR | 39.979% |
| NATURO INDIABULL LIMITED | 418.93 Million INR | 91.707% |
| Rajnish Wellness Limited | 766.84 Million INR | 95.469% |
| Rama Vision Limited | 895.7 Million INR | 96.121% |
| Vivo Bio Tech Limited | 454.51 Million INR | 92.356% |